Anbio Biotechnology to present at Medic East Africa 2023 on September 13th, 2023

August 30, 2023 11:00 PM AEST | By EIN Presswire

Google News:

Anbio Biotechnology to present at Medic East Africa 2023 on September 13th, 2023 — Image source: Kalkine Media

Recent News

ASX200-Linked Startup Kiki Exits NYC After Regulatory Crackdown

ASX300 Market Movers: Top Winners & Losers on June 17 – ASX300

ASX 200 edges lower amid geopolitical strains; Emyria, Archtis, and Ne...

ASX300 Gold Stock Faces Scrutiny Over Online Promotional Activity

FRANKFURT, HESSEN, GERMANY, August 30, 2023/EINPresswire.com/ -- Anbio Biotechnology (“Anbio”), a leading global diagnostic device and assay company, has announced its participation in the Medic East Africa at the Kenyatta International Convention Centre from September 13 to September 15, 2023. Medic East Africa is the leading healthcare and medical laboratory event in the East African Region, Anbio is looking forward to establishing more business cooperation with local partners and providing high-quality IVD products in the African region through this event.

About Anbio Biotechnology

Anbio Biotechnology is devoted to making contributions to human health and has never stopped our goal to innovate in life sciences. Driven by continuous technical development and integration, resulting from close cooperation with prestigious institutes across the world. Anbio always strives to provide total solutions in the clinical diagnosis field, by offering extensive diagnostic products including laboratory and point-of-care products.

For more information, please visit: https://www.anbio.com/

Krystal
Anbio Biotechnology
email us here
Visit us on social media:
LinkedIn

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.